// //
Skip to Content | Accesskey Details
Bringout the Health Within

Boiron Clarifies Misinformation on Some Homeopathic Medicines and Radiation Exposure

Newtown Square, Pa., Mar. 16, 2011—The radiation scare related to the nuclear plant accident in Japan has prompted questions from retailers, media and the general public about the homeopathic medicines Radium bromatum and Kali iodatum. Therefore, Boiron is educating its retailer partners to best serve their customers and to reduce possible misuse of products.

The homeopathic preparations of Radium bromatum 12X and above and Kali iodatum 1X and above are included in the Homeopathic Pharmacopoeia of the United States (HPUS) and may be sold for over-the-counter indications such as those found on Boiron’s labels. Radium bromatum HPUS is labeled for “itching or lumbar pains.” Kali iodatum HPUS is labeled for “colds with frontal sinus pain.”

Radium bromatum HPUS (the homeopathic preparation of Radium bromide) and other homeopathic preparations are not intended for, or appropriate to be used for, accidental and widespread airborne radiation exposure. Kali iodatum HPUS (the homeopathic preparation of Potassium iodide) should not be confused with the potassium iodide pills currently in the news for thyroid protection.

To obtain updated CDC recommendations associated with radiation emergencies, visit http://emergency.cdc.gov/radiation/.

###

About Boiron: Boiron, world leader in homeopathic medicines, is a 0 million public company with 4,000 employees in more than 80 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, Chestal® cough syrup and Arnicare® line of pain relievers. For nearly 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.


About Boiron: Boiron, world leader in homeopathic medicines, is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers. For more than 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.

Published: March, 2011